SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $80,159,000 | -16.5% | 567,497 | -7.5% | 0.53% | -26.8% |
Q2 2018 | $96,000,000 | -7.9% | 613,300 | -5.2% | 0.72% | -18.3% |
Q1 2018 | $104,185,000 | +2.6% | 646,828 | +4.9% | 0.88% | +0.3% |
Q4 2017 | $101,546,000 | +302.0% | 616,514 | +52.0% | 0.88% | +329.3% |
Q3 2017 | $25,262,000 | +52.3% | 405,485 | +94.6% | 0.20% | +41.4% |
Q2 2017 | $16,591,000 | +12.1% | 208,328 | 0.0% | 0.14% | +19.8% |
Q1 2017 | $14,806,000 | +39.2% | 208,328 | 0.0% | 0.12% | +16.3% |
Q4 2016 | $10,637,000 | +10.9% | 208,328 | 0.0% | 0.10% | +19.5% |
Q3 2016 | $9,594,000 | +42.1% | 208,328 | -7.0% | 0.09% | +22.5% |
Q2 2016 | $6,751,000 | -6.0% | 224,048 | 0.0% | 0.07% | -6.6% |
Q1 2016 | $7,183,000 | +17.3% | 224,048 | +113.4% | 0.08% | +49.0% |
Q4 2015 | $6,122,000 | +37.8% | 105,000 | 0.0% | 0.05% | +24.4% |
Q3 2015 | $4,444,000 | -42.0% | 105,000 | 0.0% | 0.04% | -38.8% |
Q2 2015 | $7,665,000 | +103.5% | 105,000 | +40.0% | 0.07% | +116.1% |
Q1 2015 | $3,767,000 | +37.2% | 75,000 | 0.0% | 0.03% | +10.7% |
Q4 2014 | $2,745,000 | +16.2% | 75,000 | 0.0% | 0.03% | -6.7% |
Q3 2014 | $2,363,000 | – | 75,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |